Jessica Garcia/LinkedIn
Jul 13, 2026, 18:42
Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
Jessica Garcia, Pediatric Hematologist, Hemostasis and Thrombosis Specialist at UT Southwestern Medical Center, shared a post on LinkedIn:
“Honored to present at International Society on Thrombosis and Haemostasis (ISTH) this year in Paris.
Our poster highlighted thrombin generation patterns in a patient with type 3 VWD with inhibitor on emicizumab prophylaxis, including both in vitro spiking with recombinant FVIIa and in vivo peri‑operative data.
A great discussion on how global assays can capture (and sometimes challenge) what we expect clinically.”
More posts featuring Jessica Garcia on Hemostasis Today.
-
Oct 15, 2026, 19:41Looking Beyond Platelet Counts to Quality of Life in ITP – American Society of Hematology
-
Oct 15, 2026, 19:32Markus Gregorio Barbosa: Hepatic VPS35 and Cholesterol Homeostasis
-
Oct 15, 2026, 19:18Emerging Novel Therapies for Hereditary Hemorrhagic Telangiectasia – The Lancet Haematology
-
Oct 15, 2026, 19:04Umberto Pensato: EVT Treatment Effects Across Perfusion Profiles in MeVO Stroke
-
Oct 15, 2026, 18:26Chanakya Nayudu: Presenting My Research at ISTH Congress 2026 in Paris
-
Oct 15, 2026, 18:09Maha Othman: Students Lead World Thrombosis Day 2026 Awareness Events
-
Oct 15, 2026, 17:52Jill de Mol։ Rapamycin Modulates Immune Responses in Aged Atherosclerosis
-
Oct 15, 2026, 17:41Victor Aboyans։ Think About Lipids in VTE
-
Oct 15, 2026, 17:08Babu Mia։ Targeting PPM1D to Eliminate Malignant Stem Cells in Myeloproliferative Neoplasms